EXPRS2 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - ExpreS2ion Biotech Holding AB

Watchlist Manager

Watchlist

Price: 1.385 SEK -1.07% Market Closed

Market Cap: kr32.9m

E	ExpreS2ion Biotech Holding AB STO:EXPRS2	SE
	Pearson PLC LSE:PSON	UK
A	Anheuser Busch Inbev SA F:ITKA	BE
P	Precious Shipping PCL SET:PSL	TH
	Infineon Technologies AG F:IFX	DE

Profitability Summary

ExpreS2ion Biotech Holding AB's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

75%

Negative 3Y Average Gross Margin

-51%

Gross Margin is Increasing

-209% > 75%

Negative Operating Margin

-270%

Negative 3Y Average Operating Margin

-822%

Operating Margin is Increasing

-2 145% > -270%

Negative Net Margin

-225%

Negative 3Y Average Net Margin

-611%

Net Margin is Increasing

-1 968% > -225%

Negative Free Cash Flow Margin

-286%

Negative 3Y Average Free Cash Flow Margin

-769%

Free Cash Flow Margin is Increasing

-1 884% > -286%

Negative ROE

-93%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-312%

ROIC is Increasing

-769% > -157%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.